A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
Clinical trial NCT03523858 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03523858
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-28
- Primary completion
- 2026-10-22
- Enrollment
- 927
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.